Issues in Implementation of Adolescent Vaccination in Schools

简介（由申请人提供）：摘要2012年，总统癌症小组建议在州一级促进学校青少年疫苗接种计划的实施，以增加HPV疫苗接种。国家指南建议青少年接种致癌HPV疫苗，以降低宫颈癌和其他HPV相关癌症的发病率。然而，在2011年，只有三分之一的13-17岁的美国女孩接种了所有三种推荐的HPV疫苗剂量，这一比例在少数民族和低收入青少年中更低。在一些地区，学校的疫苗接种项目已经成功地实施了流感和乙肝疫苗接种，但在美国，这类项目在HPV疫苗接种方面仍未得到充分利用。为了提高青少年疫苗接种项目的质量和有效性，需要更好地了解hpv相关癌症和青少年疫苗接种覆盖率的趋势和差异，以及与在学校提供青少年疫苗接种项目的设计和实施相关的问题。我们建议在乔治亚州的亚特兰大召开一次全国会议，以(1)回顾目前hpv相关癌症和青少年疫苗接种覆盖率的差距，(2)讨论目前实施学校青少年疫苗接种计划的最佳做法、机遇和挑战。40名利益攸关方将出席会议，包括提供者、研究人员、临床医生、保险公司、公共卫生专业人员、决策者和教育工作者。由保健服务、癌症预防、青少年疫苗接种、保险、教育、临床免疫和公共卫生政策等领域的专家组成的会议咨询委员会将对最终议程、会议受邀者名单和战略会议方法提供投入。报告、小组讨论和促进讨论将涵盖拟议的会议主题：卫生信息技术和数据管理、与医疗家庭提供者的协调、患者安全、家长同意、学校系统负担以及通过公共和私人支付方进行报销。北卡罗莱纳大学的项目团队将负责会议组织，并将制作一份白皮书，概述会议期间提出的证据、讨论的问题和研究议程，发表在同行评审的期刊上，并通过合作伙伴组织传播。

DESCRIPTION (provided by applicant): Abstract In 2012, the President's Cancer Panel recommended the promotion of state-level implementation of school-located adolescent vaccination programs to increase HPV vaccination. National guidelines recommend vaccination of adolescents against oncogenic HPV to reduce rates of cervical and other HPV-associated cancers. However, in 2011 only one third of U.S. girls aged 13-17 had received all three recommended HPV vaccine doses, and these rates were lower among minority and low-income teens. School-located vaccination programs have been successfully implemented for influenza and hepatitis B vaccination in some areas, but such programs remain underutilized for vaccination against HPV in the United States. In order to improve the quality and effectiveness of adolescent vaccine programs, a greater understanding is needed of trends and disparities in HPV-associated cancers and adolescent vaccination coverage, as well as of issues related to the design and implementation of programs to deliver adolescent vaccinations in schools. We propose to hold a national meeting in Atlanta, Georgia, to (1) review current disparities in HPV-associated cancers and adolescent vaccination coverage, and (2) discuss current best practices, opportunities, and challenges in implementing school-located adolescent vaccination programs. The meeting will be attended by 40 stakeholders, including providers, researchers, clinicians, insurers, public health professionals, policy makers, and educators. A conference advisory committee comprised of experts in the areas of health care services, cancer prevention, adolescent vaccination, insurance, education, clinical immunization, and public health policy will provide input on the final agenda, list of meeting invitees, and strategic meetig approach. Presentations, panels, and facilitated discussions will cover proposed meeting themes: health information technology and data management, coordination with medical home providers, patient safety, parental consent, school system burdens, and reimbursement via public and private payers. The University of North Carolina-based project team will be responsible for meeting organization and will produce a white paper summarizing the evidence presented, issues discussed, and research agenda developed during the meeting for publication in a peer-reviewed journal and dissemination via partner organizations.